Trial Profile
A Phase 3b, Multicentre, Randomised, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of DYSPORT® Using 2mL Dilution in Adults With Cervical Dystonia.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 29 Oct 2021
Price :
$35
*
At a glance
- Drugs Botulinum-Toxin-A (Primary)
- Indications Torticollis
- Focus Therapeutic Use
- Sponsors Ipsen
- 22 Sep 2021 Results assessing meta-analysis of patient-level data from four randomized, placebo-controlled studies (Truong et al 2005 & 2010, NCT01261611, NCT01753310) of AboBoNT-A 500U and three associated open-label extension studies were presented at the 25th International Congress of Parkinson's Disease and Movement Disorders.
- 22 Apr 2021 Results of meta analyses of patient level data from four randomized, placebo controlled studies (Truong et al 2005 & 2010, NCT01261611, NCT01753310) of AboBoNT-A 500U and three associated open-label extension studies presented at the 73rd Annual Meeting of the American Academy of Neurology
- 08 Jun 2017 Primary endpoint (Change from baseline in Toronto Western Spasmodic Torticollis Rating Scale (TWSTRS) total score) has been met, according to the results presented at the 21st International Congress of Parkinson's Disease and Movement Disorders